These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18792066)

  • 1. Decreasing disparity in liver transplantation among white and Asian patients with hepatocellular carcinoma : California, 1998-2005.
    Robbins AS; Daily MF; Aoki CA; Chen MS; Troppmann C; Perez RV
    Cancer; 2008 Oct; 113(8):2173-9. PubMed ID: 18792066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare disparities in Asians and Pacific Islanders with hepatocellular cancer.
    Wong LL; Hernandez B; Kwee S; Albright CL; Okimoto G; Tsai N
    Am J Surg; 2012 Jun; 203(6):726-32. PubMed ID: 22227170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007.
    Robbins AS; Cox DD; Johnson LB; Ward EM
    Cancer; 2011 Oct; 117(19):4531-9. PubMed ID: 21448933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.
    Siegel AB; McBride RB; El-Serag HB; Hershman DL; Brown RS; Renz JF; Emond J; Neugut AI
    Am J Gastroenterol; 2008 Jan; 103(1):120-7. PubMed ID: 18005365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.
    Yang D; Hanna DL; Usher J; LoCoco J; Chaudhari P; Lenz HJ; Setiawan VW; El-Khoueiry A
    Cancer; 2014 Dec; 120(23):3707-16. PubMed ID: 25081299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
    Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
    World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S.
    Miller BA; Chu KC; Hankey BF; Ries LA
    Cancer Causes Control; 2008 Apr; 19(3):227-56. PubMed ID: 18066673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approximately one-half of patients with early-stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post-MELD exception era.
    Devaki P; Wong RJ; Marupakula V; Nangia S; Nguyen L; Ditah IC; Ehrinpreis MN; Nguyen MH
    Cancer; 2014 Jun; 120(11):1725-32. PubMed ID: 24590359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disentangling the effects of race and socioeconomic factors on liver transplantation rates for hepatocellular carcinoma.
    Sarpel U; Suprun M; Sofianou A; Berger Y; Tedjasukmana A; Sekendiz Z; Bagiella E; Schwartz ME
    Clin Transplant; 2016 Jun; 30(6):714-21. PubMed ID: 27027869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis.
    Nart D; Arikan C; Akyildiz M; Yuce G; Demirpolat G; Zeytunlu M; Karasu Z; Aydogdu S; Killi R; Yuzer Y; Tokat Y; Kilic M
    Transplant Proc; 2003 Dec; 35(8):2986-90. PubMed ID: 14697957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma.
    Yu JC; Neugut AI; Wang S; Jacobson JS; Ferrante L; Khungar V; Lim E; Hershman DL; Brown RS; Siegel AB
    Cancer; 2010 Apr; 116(7):1801-9. PubMed ID: 20143441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological differentiation predicts post-liver transplantation survival time.
    Li WX; Li Z; Gao PJ; Gao J; Zhu JY
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):201-8. PubMed ID: 24388339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
    Artinyan A; Mailey B; Sanchez-Luege N; Khalili J; Sun CL; Bhatia S; Wagman LD; Nissen N; Colquhoun SD; Kim J
    Cancer; 2010 Mar; 116(5):1367-77. PubMed ID: 20101732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does race affect management and survival in hepatocellular carcinoma in the United States?
    Hoehn RS; Hanseman DJ; Wima K; Ertel AE; Paquette IM; Abbott DE; Shah SA
    Surgery; 2015 Nov; 158(5):1244-51. PubMed ID: 25958069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in clinical and demographic characteristics among Asian/Pacific Islander and Non-Hispanic White newly diagnosed lung cancer patients.
    Patel PB; Alpert N; Taioli E; Flores R
    Cancer Causes Control; 2022 Apr; 33(4):547-557. PubMed ID: 35043281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
    Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
    J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
    Mazzaferro V; Sposito C; Zhou J; Pinna AD; De Carlis L; Fan J; Cescon M; Di Sandro S; Yi-Feng H; Lauterio A; Bongini M; Cucchetti A
    Gastroenterology; 2018 Jan; 154(1):128-139. PubMed ID: 28989060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.